Health & Environmental Research Online (HERO)


Print Feedback Export to File
6028026 
Journal Article 
Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis 
Cornejo, CJ; Eunson, T; Harlan, J; Karsan, A; Kay, M; Morrison, RS; Stempien-Otero, A; Winn, R; Xiang, H 
1999 
Yes 
Journal of Biological Chemistry
ISSN: 0021-9258
EISSN: 1083-351X 
274 
12 
8039-8045 
Endothelial cell death may contribute to tissue injury from ischemia. Little is known, however, about the characteristics of endothelial cell death in response to hypoxia. Using an in vitro model, we found that human umbilical vein endothelial cells were resistant to hypoxia-induced cell death with only a 2% reduction in viability at 24 h and 45% reduction in viability at 48 h. Overexpression of a mutant, IkappaBalpha, via adenoviral vector did not potentiate cell death in hypoxia, indicating that nuclear factor-kappaB activation was not involved in cytoprotection. Cell death in hypoxia was determined to be apoptotic by 3' labeling of DNA using terminal deoxynucleotidyl transferase staining and reversibility of cell death with a caspase inhibitor. Exposure of endothelial cells to hypoxia did not alter levels of proapoptotic and antiapoptotic Bcl-2 family members Bax and Bcl-XL by immunoblot analysis. In contrast, changes in p53 protein levels correlated with the induction of apoptosis in hypoxic endothelial cells. Inhibition of the proteasome increased p53 protein levels and accelerated cell death in hypoxia. Overexpression of p53 by adenoviral transduction was sufficient to initiate apoptosis of normoxic endothelial cells. These data provide a framework for the study of factors regulating endothelial cell survival and death in hypoxia. 
BAX protein, human; BCL2L1 protein, human; DNA-Binding Proteins; I-kappa B Proteins; NFKBIA protein, human; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; acetyl-leucinal-nor-leucinal; bcl-2-Associated X Protein; bcl-X Protein